AIRS Medical’s SwiftMR® Receives FDA Clearance to Work in Conjunction with OEM Deep Learning Reconstruction Solutions

CHICAGO, April 15, 2026 /PRNewswire/ -- AIRS Medical today announced that SwiftMR®, an FDA 510(k)-cleared, vendor-neutral MRI image enhancement solution, has received clearance to operate in conjunction with deep learning (DL) reconstruction pipelines from original equipment manufacturers (OEM).

SwiftMR works alongside OEM DL solutions in two ways:

In cases where an OEM DL solution is already installed, SwiftMR works in conjunction to deliver additional scan time reduction. At an imaging center with a GE 3T scanner using AIR Recon DL, SwiftMR further reduced already-accelerated routine brain scans from 15 to 9 minutes.

In cases where an OEM DL solution does not cover a sequence, SwiftMR extends coverage and enables AI-powered image enhancement and scan time reduction across all pulse sequences and all body parts. SwiftMR’s full coverage is FDA cleared and has been in clinical use since 2023.

Sign up for Blog Updates